| Correction to: Virologic Outcomes with Molnupiravir in Nonhospitalized Adult Patients with COVID-19 from the Randomized, Placebo-Controlled MOVe-OUT Trial JM Strizki, JA Grobler, N Murgolo, A Fridman, MG Johnson, J Du, ... Infectious Diseases and Therapy 13 (5), 1159, 2024 | | 2024 |
| Virologic Outcomes with Molnupiravir in Nonhospitalized Adult Patients with COVID-19 from the Randomized, Placebo-Controlled MOVe-OUT Trial (vol 12, pg 2725, 2023) JM Strizki, JA Grobler, N Murgolo, A Fridman, MG Johnson, J Du, ... INFECTIOUS DISEASES AND THERAPY, 2024 | | 2024 |
| Complex molecule substructure identification systems, apparatuses and methods A Fridman, A Bagchi, X Yu, M Cancilla US Patent 11,854,664, 2023 | | 2023 |
| Structural characterization of M8C10, a neutralizing antibody targeting a highly conserved prefusion-specific epitope on the metapneumovirus fusion trimerization interface X Xiao, Z Wen, Q Chen, JM Shipman, J Kostas, JC Reid, C Warren, ... Journal of Virology 97 (12), e01052-23, 2023 | | 2023 |
| Virologic outcomes with molnupiravir in non-hospitalized adult patients with COVID-19 from the randomized, placebo-controlled MOVe-OUT trial JM Strizki, JA Grobler, N Murgolo, A Fridman, MG Johnson, J Du, ... Infectious Diseases and Therapy 12 (12), 2725-2743, 2023 | 1 | 2023 |
| Discovery and multimerization of cross-reactive single-domain antibodies against SARS-like viruses to enhance potency and address emerging SARS-CoV-2 variants SA Hollingsworth, CL Noland, K Vroom, A Saha, M Sam, Q Gao, H Zhou, ... Scientific Reports 13 (1), 13668, 2023 | 6 | 2023 |
| Stabilized rsv f proteins and uses thereof L Zhang, A Fridman, E Durr, A Bett US Patent App. 18/068,867, 2023 | | 2023 |
| Stabilized RSV F proteins and uses thereof L Zhang, A Fridman, E Durr, A Bett US Patent 11,566,051, 2023 | | 2023 |
| Antigenic glycoprotein e polypeptides, compositions, and methods of use thereof A Fridman, JD Galli, D Wang, L Zhang US Patent App. 17/626,206, 2022 | | 2022 |
| Profiling of hMPV F-specific antibodies isolated from human memory B cells X Xiao, A Fridman, L Zhang, P Pristatsky, E Durr, M Minnier, A Tang, ... Nature Communications 13 (1), 2546, 2022 | 10 | 2022 |
| Method for identifying high affinity monoclonal antibody heavy and light chain pairs from high throughput screens of b-cell and hybridoma libraries E Durr, Y Liu, Z Chen, A Fridman US Patent App. 17/299,559, 2022 | | 2022 |
| Evaluation of HSV-2 GE Binding to IgG-Fc and Application for Vaccine Development JD Galli, M Horton, E Durr, GJ Heidecker, D Freed, A Fridman, D Wang, ... Vaccines 10 (2), 184, 2022 | 1 | 2022 |
| Evaluation of HSV-2 gE Binding to IgG-Fc and Application for Vaccine Development. Vaccines 2022, 10, 184 JD Galli, M Horton, E Durr, GJ Heidecker, D Freed, A Fridman, D Wang, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
| Development of a microneutralization assay for HSV-2 MS Horton, M Minnier, S Cosmi, K Cox, J Galli, J Peters, N Sullivan, ... Journal of Virological Methods 297, 114268, 2021 | | 2021 |
| Cut Vertex Method for Identifying Complex Molecule Substructures A Fridman, A Bagchi, X Yu, M Cancilla US Patent App. 16/973,197, 2021 | | 2021 |
| Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing X He, S Quan, M Xu, S Rodriguez, SL Goh, J Wei, A Fridman, ... Proceedings of the National Academy of Sciences 118 (15), e2025866118, 2021 | 65 | 2021 |
| Generation of a SARS-CoV-2 replicon as a model system to dissect virus replication and antiviral inhibition X He, S Quan, M Xu, S Rodriguez, SL Goh, J Wei, A Fridman, ... bioRxiv, 2020.12. 12.422532, 2020 | 2 | 2020 |
| Safety, tolerability and immunogenicity of V934/V935 hTERT vaccination in cancer patients with selected solid tumors: a phase I study L Aurisicchio, A Fridman, D Mauro, R Sheloditna, A Chiappori, A Bagchi, ... Journal of translational medicine 18, 1-8, 2020 | 25 | 2020 |
| Metabolite identification of therapeutic peptides and proteins by top-down differential mass spectrometry and metabolite database matching X Yu, A Fridman, A Bagchi, S Xu, KA Kwasnjuk, P Lu, MT Cancilla Analytical Chemistry 92 (12), 8298-8305, 2020 | 9 | 2020 |
| Influenza hemagglutinin protein vaccines JA Flynn, L Zhang, K Babaoglu, A Fridman, D Nickle US Patent App. 16/343,272, 2019 | | 2019 |
